ArticleFrontiers in artificial intelligence2026
Towards cross-center head and neck cancer detection: a multi-level domain alignment exploration.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Deep learning models for head and neck cancer (HNC) detection from computed tomography (CT) hold significant promise for improving early detection-a critical priority given that 5-year survival drops from 84% for localized disease to 39% for metastatic cases. However, robust cross-center deployment remains challenging because scanner vendors, acquisition protocols, reconstruction Q15 kernels, and patient populations vary across hospitals. To address this challenge, we propose MDA-Net, a multi-level domain generalization framework for cross-center 3D CT classification. The final MDA-Net configuration is deliberately designed as a training-time generalization strategy: it does not use target-domain batches, target-domain labels, target-domain statistics, or adaptive updates during inference. Instead, it performs a single forward pass with fixed parameters on each unseen target CT volume. Methods: Our framework integrates three complementary levels: (i) input-level inverse frequency weighted sampling, Fourier Domain Adaptation (FDA), and Mixup augmentation to mitigate class imbalance and diversify source styles; (ii) feature-level IBN-enhanced 3D ResNet-18, DANN, and CORAL to learn style-invariant and statistically aligned representations; and (iii) optimization-level Sharpness-Aware Minimization (SAM) and Stochastic Weight Averaging (SWA) to stabilize training under style perturbation. We evaluate MDA-Net on a multi-center dataset comprising 1,081 cases from three hospitals under a strict leave-one-center-out protocol. Results: On the primary Foshan target domain, MDA-Net improves AUC from 0.5121 to 0.5869 and ACC from 0.4829 to 0.6000; reverse validation on another held-out center further yields AUC = 0.5887. Our stepwise ablation demonstrates that IBN provides the largest single-component gain, while FDA and CORAL become beneficial only when combined with SAM, SWA, Mixup, and a moderate adversarial weight of λ = 0.1. Conclusions: These results position MDA-Net as an exploratory yet practical, privacy-preserving, and computationally efficient domain generalization strategy for cross-center HNC detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.